Modelos europeos de telemedicina, como el servicio finlandés Medilux, permiten realizar consultas médicas online mediante un cuestionario clínico, sin acudir a una consulta presencial.

Is Cusp Overlapping Projection the New Self-Expandable Valve Implantation Technique?

In Europe and the US, aortic stenosis is the most frequent cause of valve intervention, both surgical and percutaneous, and, as we all know, TAVR has made great progress in this regard. 

¿Fin de la discusión sobre el impacto del marcapaso post TAVI?

However, this technique has an Achilles heel when it comes to self-expandable valves: definite pacemaker implantation rate is 3 to 4 times higher with TAVR vs surgery. This generates major costs, higher risk of inhospital complications and, at followup, higher tricuspid failure.

Higher implantation or Cusp Overlapping Projection (COP) might solve this inconvenience.

The present study looked at 444 patients undergoing TAVR. 175 of these procedures were done using the CPO technique (39.4%) and the rest, the standard technique. 

Even though the populations were similar, there were some differences in age, hypertension, stroke, STS score and the presence of first-degree AV-block. 

Read also: Cusp Overlap for Higher CoreValve Implantation.

Mean gradient was 45 mmHg, perimeter was 74 mm and calcium score 2,587 U Agatston.

Procedural success rate was 96%. The most used access was right femoral, 30% required pre-dilation and 30.9% post-dilation.

Mortality was 0.23, stroke 1.1, valve embolization was 0.4, major bleeding was 1.1 and high degree A-V block, 12.2%. There were no differences between the groups but the need for definite pacemaker was lower with COP (12.6 vs. 21.2% (P= 0.02; RR: 0.59; 95% CI: 0.38-0.93)), as was depth measured from the non-coronary cusp to distal prostheses end: 4.2 mm vs.5.14 mm (P=<0.001)

Read also: Tricuspid valve: Is Percutaneous Intervention Feasible in Patients with Definite Pacemaker?

To match the populations researchers used Propensity Score, which left 161 pairs of patients. There were no differences in characteristics, or evolution, which were similar to prior results. 

The need for definite pacemaker implantation was lower in the COP population: 11.8% vs 21.7% respectively (P = 0.03; RR: 0.54; 95% CI: 0.32-0.91), aa was mean implantation depth measured from non-coronary sinus 4.2±2.1 mm vs. 5.3±2.6 mm (P < 0.001).

Conclusion

The present study showed that the COP technique significantly reduces the need for pacemaker implantation with self-expandable valves compared to the standard technique, with similar complications rate. 

Dr. Carlos Fava - Consejo Editorial SOLACI

Dr. Carlos Fava.
Member of the Editorial Board, SOLACI.org

Original Title: Permanent Pacemaker Reduction Using Cusp-Overlapping Projection in TAVR A Propensity Score Analysis.

Reference: Isaac Pascual, et al. J Am Coll Cardiol Intv 2022;15:150–161.


Subscribe to our weekly newsletter

Get the latest scientific articles on interventional cardiology

More articles by this author

EuroPCR 2026 | TAVI in Women: Do Supra-Annular Valves Offer a True Hemodynamic Advantage?

Women represent a particularly challenging population for TAVI, as they often have smaller aortic annuli, greater frailty, and an increased risk of prosthesis-patient mismatch....

EuroPCR 2026 | TAVI or Surgery in Younger Patients? Quality of Life and 3-Year Outcomes from NOTION-2

The expansion of TAVI into younger and lower surgical-risk populations has sparked a new debate: beyond mortality and stroke, which strategy provides better functional...

EuroPCR 2026 | MELA Registry: Myval Showed Lower Aortic Regurgitation Rates in Patients With Large Aortic Annuli

This presentation, delivered by Dr. Salvatore Giordano at EuroPCR 2026, detailed the results of the MELA Registry, a multicenter study comparing the performance of...

EuroPCR 2026 | LANDMARK Trial: Two-Year Results Showed Comparable Efficacy Between Myval and Contemporary TAVI Valves

The LANDMARK trial presentation, delivered by Prof. Patrick W. Serruys at EuroPCR 2026, detailed the two-year clinical outcomes of contemporary transcatheter aortic valve implantation...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img
Jornadas Guatemala 2026

Recent Articles

EuroPCR 2026 | TAVI in Women: Do Supra-Annular Valves Offer a True Hemodynamic Advantage?

Women represent a particularly challenging population for TAVI, as they often have smaller aortic annuli, greater frailty, and an increased risk of prosthesis-patient mismatch....

EuroPCR 2026 | TAVI or Surgery in Younger Patients? Quality of Life and 3-Year Outcomes from NOTION-2

The expansion of TAVI into younger and lower surgical-risk populations has sparked a new debate: beyond mortality and stroke, which strategy provides better functional...

EuroPCR 2026 | MELA Registry: Myval Showed Lower Aortic Regurgitation Rates in Patients With Large Aortic Annuli

This presentation, delivered by Dr. Salvatore Giordano at EuroPCR 2026, detailed the results of the MELA Registry, a multicenter study comparing the performance of...